Patient Centricity WG

As part of PMDA's patient engagement efforts, this WG exchanges views with patient groups and patient advocate groups and examines how to make the most of patients' voices in drug and medical device development.
(Activity period: From May, 2019)

Activities

Guidance on Patient Engagement
For promoting patient engagement of PMDA, we developed this guidance as basic activity guidelines for PMDA and its officers and employees to refer to in order to achieve this goal.

• Pharmaceuticals and Medical Devices Agency Guidance on Patient Participation (September 7, 2021)[119KB]

Collaboration in symposia and workshops
We actively engage from the planning stage in symposia and workshops related to patient engagement to promote patient-centered collaboration among industry, academia, and government.

Collaboration with patient groups and patient advocate groups
As part of our ongoing collaboration with various patient groups and patient advocate groups, we exchange opinions and develop materials as needed.
 

The activities conducted over the last five years.

Presentations

 

• The outlook for Patient involvement in Medical Device Development ~Japanese Regulatory View~[318KB]

Japan-US HBD East 2021 Think Tank Meeting, Web, January 2022

 

• PMDA’s Patient Participation Activities[0.99MB]

18th DIA Japan Annual Meeting 2021, Web, October 2021